Skip to main content
Premium Trial:

Request an Annual Quote

Interpace Diagnostics, SelectHealth Sign Coverage Agreement for Thyroid Cancer Tests

NEW YORK— Interpace Diagnostics announced today that it has signed an agreement with SelectHealth/Intermountain Healthcare to offer its thyroid cancer detection assays to SelectHealth's 850,000 members in Utah and Idaho. 

As part of the agreement, physicians across SelectHealth's entire network can now use Interpace's ThyGeNext and ThyraMir assays to test questionable thyroid nodules for potential evidence of thyroid cancer.

In addition, Interpace said it will act as an in-network laboratory for these services to SelectHealth's members. 

"This continues the trend we have seen among other healthcare plans, both national and regional, to make our unique ThyGeNext/ThyraMir combination tests available to their members," Interpace CEO Jack Stover said in a statement.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.